HEADER SIGNALING PROTEIN 06-NOV-20 7AW2 TITLE MERTK KINASE DOMAIN WITH TYPE 1.5 INHIBITOR FROM A DNA-ENCODED LIBRARY COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE MER; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN (571-864); COMPND 5 SYNONYM: PROTO-ONCOGENE C-MER,RECEPTOR TYROSINE KINASE MERTK; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MERTK, MER; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: STAR; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS TYROSINE KINASE, INHIBITOR, TYPE1.5 KINASE INHIBITOR, STRUCTURE-BASED KEYWDS 2 DRUG DESIGN, DNA-ENCODED LIBRARY, ONCOLOGY, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR M.SCHIMPL,J.W.M.NISSINK,C.BLACKETT,K.GOLDBERG,E.J.HENNESSY, AUTHOR 2 E.HARDAKER,W.MCCOULL,L.MCMURRAY,O.COLLINGWOOD,R.OVERMAN,A.PFLUG, AUTHOR 3 M.PRESTON,P.RAWLINS,E.RIVERS,P.SMITH,E.UNDERWOOD,C.TRUMAN, AUTHOR 4 J.WARWICKER,J.WINTER,S.WOODCOCK REVDAT 4 01-MAY-24 7AW2 1 REMARK REVDAT 3 07-APR-21 7AW2 1 JRNL REVDAT 2 24-MAR-21 7AW2 1 JRNL REVDAT 1 03-MAR-21 7AW2 0 JRNL AUTH J.W.M.NISSINK,S.BAZZAZ,C.BLACKETT,M.A.CLARK,O.COLLINGWOOD, JRNL AUTH 2 J.S.DISCH,D.GIKUNJU,K.GOLDBERG,J.P.GUILINGER,E.HARDAKER, JRNL AUTH 3 E.J.HENNESSY,R.JETSON,A.D.KEEFE,W.MCCOULL,L.MCMURRAY, JRNL AUTH 4 A.OLSZEWSKI,R.OVERMAN,A.PFLUG,M.PRESTON,P.B.RAWLINS, JRNL AUTH 5 E.RIVERS,M.SCHIMPL,P.SMITH,C.TRUMAN,E.UNDERWOOD,J.WARWICKER, JRNL AUTH 6 J.WINTER-HOLT,S.WOODCOCK,Y.ZHANG JRNL TITL GENERATING SELECTIVE LEADS FOR MER KINASE INHIBITORS-EXAMPLE JRNL TITL 2 OF A COMPREHENSIVE LEAD-GENERATION STRATEGY. JRNL REF J.MED.CHEM. V. 64 3165 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 33683117 JRNL DOI 10.1021/ACS.JMEDCHEM.0C01904 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.73 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 18540 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.208 REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.238 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 927 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 46 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.11 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 88.38 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 404 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2996 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 384 REMARK 3 BIN R VALUE (WORKING SET) : 0.2968 REMARK 3 BIN FREE R VALUE : 0.3584 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.95 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 20 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2103 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 30 REMARK 3 SOLVENT ATOMS : 69 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 57.22 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 65.54 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 8.36840 REMARK 3 B22 (A**2) : -14.75050 REMARK 3 B33 (A**2) : 6.38210 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.310 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.209 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.171 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.206 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.172 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.943 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.937 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2179 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2952 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 740 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 358 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2179 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 280 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2552 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.02 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.87 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.67 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 15.2423 29.0035 -7.6245 REMARK 3 T TENSOR REMARK 3 T11: -0.0845 T22: -0.0852 REMARK 3 T33: -0.0740 T12: 0.0284 REMARK 3 T13: -0.0028 T23: -0.0381 REMARK 3 L TENSOR REMARK 3 L11: 3.2491 L22: 1.1612 REMARK 3 L33: 2.4865 L12: 0.8554 REMARK 3 L13: 0.8293 L23: 0.3636 REMARK 3 S TENSOR REMARK 3 S11: 0.1449 S12: -0.0804 S13: 0.0297 REMARK 3 S21: 0.0771 S22: 0.0775 S23: -0.0459 REMARK 3 S31: -0.1383 S32: -0.0530 S33: -0.2224 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7AW2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-NOV-20. REMARK 100 THE DEPOSITION ID IS D_1292112044. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-NOV-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SOLEIL REMARK 200 BEAMLINE : PROXIMA 2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98010 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.17 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18583 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 48.440 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : 0.05900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.15 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.2 REMARK 200 DATA REDUNDANCY IN SHELL : 6.60 REMARK 200 R MERGE FOR SHELL (I) : 1.23700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: INTERNAL MODEL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.56 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.26 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.5 MM PROTEIN WAS CRYSTALLISED IN 4.3 REMARK 280 M SODIUM CHLORIDE, 0.1 M TRIS PH 8.5 AND SOAKED FOR 24 H WITH 20 REMARK 280 MM COMPOUND AND 20 % DMSO, VAPOR DIFFUSION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 35.68500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 35.68500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 46.14000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 47.17500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 46.14000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 47.17500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 35.68500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 46.14000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 47.17500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 35.68500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 46.14000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 47.17500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMER REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 567 REMARK 465 GLY A 596 REMARK 465 GLU A 597 REMARK 465 LEU A 623 REMARK 465 ASP A 624 REMARK 465 GLN A 662 REMARK 465 GLY A 663 REMARK 465 ILE A 664 REMARK 465 SER A 745 REMARK 465 LYS A 746 REMARK 465 LYS A 747 REMARK 465 ILE A 748 REMARK 465 TYR A 749 REMARK 465 SER A 750 REMARK 465 GLY A 751 REMARK 465 ASP A 752 REMARK 465 TYR A 753 REMARK 465 TYR A 754 REMARK 465 ARG A 755 REMARK 465 GLN A 756 REMARK 465 GLY A 757 REMARK 465 ARG A 758 REMARK 465 ILE A 759 REMARK 465 ALA A 760 REMARK 465 LYS A 761 REMARK 465 MET A 762 REMARK 465 ASP A 863 REMARK 465 VAL A 864 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 568 OG REMARK 470 GLU A 571 CG CD OE1 OE2 REMARK 470 GLU A 572 CG CD OE1 OE2 REMARK 470 GLU A 578 CG CD OE1 OE2 REMARK 470 PHE A 598 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU A 609 CG CD OE1 OE2 REMARK 470 LYS A 622 CG CD CE NZ REMARK 470 ASN A 625 CG OD1 ND2 REMARK 470 GLN A 628 CG CD OE1 NE2 REMARK 470 ARG A 629 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 630 CG CD OE1 OE2 REMARK 470 GLU A 658 CG CD OE1 OE2 REMARK 470 MET A 659 CG SD CE REMARK 470 LYS A 666 CG CD CE NZ REMARK 470 ARG A 693 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 722 CD NE CZ NH1 NH2 REMARK 470 LEU A 744 CG CD1 CD2 REMARK 470 ASP A 774 CG OD1 OD2 REMARK 470 ARG A 775 CG CD NE CZ NH1 NH2 REMARK 470 VAL A 776 CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 628 -82.47 -119.50 REMARK 500 ASP A 723 39.82 -151.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue S4W A 901 DBREF 7AW2 A 571 864 UNP Q12866 MERTK_HUMAN 571 864 SEQADV 7AW2 GLY A 567 UNP Q12866 EXPRESSION TAG SEQADV 7AW2 SER A 568 UNP Q12866 EXPRESSION TAG SEQADV 7AW2 HIS A 569 UNP Q12866 EXPRESSION TAG SEQADV 7AW2 MET A 570 UNP Q12866 EXPRESSION TAG SEQADV 7AW2 ARG A 591 UNP Q12866 LYS 591 ENGINEERED MUTATION SEQADV 7AW2 ARG A 693 UNP Q12866 LYS 693 ENGINEERED MUTATION SEQADV 7AW2 ARG A 702 UNP Q12866 LYS 702 ENGINEERED MUTATION SEQADV 7AW2 ARG A 856 UNP Q12866 LYS 856 ENGINEERED MUTATION SEQRES 1 A 298 GLY SER HIS MET GLU GLU LEU GLN ASN LYS LEU GLU ASP SEQRES 2 A 298 VAL VAL ILE ASP ARG ASN LEU LEU ILE LEU GLY ARG ILE SEQRES 3 A 298 LEU GLY GLU GLY GLU PHE GLY SER VAL MET GLU GLY ASN SEQRES 4 A 298 LEU LYS GLN GLU ASP GLY THR SER LEU LYS VAL ALA VAL SEQRES 5 A 298 LYS THR MET LYS LEU ASP ASN SER SER GLN ARG GLU ILE SEQRES 6 A 298 GLU GLU PHE LEU SER GLU ALA ALA CYS MET LYS ASP PHE SEQRES 7 A 298 SER HIS PRO ASN VAL ILE ARG LEU LEU GLY VAL CYS ILE SEQRES 8 A 298 GLU MET SER SER GLN GLY ILE PRO LYS PRO MET VAL ILE SEQRES 9 A 298 LEU PRO PHE MET LYS TYR GLY ASP LEU HIS THR TYR LEU SEQRES 10 A 298 LEU TYR SER ARG LEU GLU THR GLY PRO ARG HIS ILE PRO SEQRES 11 A 298 LEU GLN THR LEU LEU ARG PHE MET VAL ASP ILE ALA LEU SEQRES 12 A 298 GLY MET GLU TYR LEU SER ASN ARG ASN PHE LEU HIS ARG SEQRES 13 A 298 ASP LEU ALA ALA ARG ASN CYS MET LEU ARG ASP ASP MET SEQRES 14 A 298 THR VAL CYS VAL ALA ASP PHE GLY LEU SER LYS LYS ILE SEQRES 15 A 298 TYR SER GLY ASP TYR TYR ARG GLN GLY ARG ILE ALA LYS SEQRES 16 A 298 MET PRO VAL LYS TRP ILE ALA ILE GLU SER LEU ALA ASP SEQRES 17 A 298 ARG VAL TYR THR SER LYS SER ASP VAL TRP ALA PHE GLY SEQRES 18 A 298 VAL THR MET TRP GLU ILE ALA THR ARG GLY MET THR PRO SEQRES 19 A 298 TYR PRO GLY VAL GLN ASN HIS GLU MET TYR ASP TYR LEU SEQRES 20 A 298 LEU HIS GLY HIS ARG LEU LYS GLN PRO GLU ASP CYS LEU SEQRES 21 A 298 ASP GLU LEU TYR GLU ILE MET TYR SER CYS TRP ARG THR SEQRES 22 A 298 ASP PRO LEU ASP ARG PRO THR PHE SER VAL LEU ARG LEU SEQRES 23 A 298 GLN LEU GLU ARG LEU LEU GLU SER LEU PRO ASP VAL HET S4W A 901 30 HETNAM S4W 5-(2'-CHLORO-[1,1'-BIPHENYL]-4-YL)-N-(IMIDAZO[1,2- HETNAM 2 S4W A]PYRIDIN-6-YLMETHYL)-N-METHYL-1,3,4-OXADIAZOL-2-AMINE HETSYN S4W 5-[4-(2-CHLOROPHENYL)PHENYL]-~{N}-(IMIDAZO[1,2- HETSYN 2 S4W A]PYRIDIN-6-YLMETHYL)-~{N}-METHYL-1,3,4-OXADIAZOL-2- HETSYN 3 S4W AMINE FORMUL 2 S4W C23 H18 CL N5 O FORMUL 3 HOH *69(H2 O) HELIX 1 AA1 MET A 570 VAL A 581 1 12 HELIX 2 AA2 ASP A 583 ASN A 585 5 3 HELIX 3 AA3 GLN A 628 ASP A 643 1 16 HELIX 4 AA4 ASP A 678 SER A 686 1 9 HELIX 5 AA5 PRO A 696 ARG A 717 1 22 HELIX 6 AA6 ALA A 725 ARG A 727 5 3 HELIX 7 AA7 PRO A 763 ILE A 767 5 5 HELIX 8 AA8 ALA A 768 ASP A 774 1 7 HELIX 9 AA9 THR A 778 THR A 795 1 18 HELIX 10 AB1 GLN A 805 HIS A 807 5 3 HELIX 11 AB2 GLU A 808 HIS A 815 1 8 HELIX 12 AB3 LEU A 826 CYS A 836 1 11 HELIX 13 AB4 ASP A 840 ARG A 844 5 5 HELIX 14 AB5 THR A 846 SER A 860 1 15 SHEET 1 AA1 5 LEU A 587 GLY A 594 0 SHEET 2 AA1 5 VAL A 601 LYS A 607 -1 O VAL A 601 N LEU A 593 SHEET 3 AA1 5 SER A 613 THR A 620 -1 O VAL A 618 N MET A 602 SHEET 4 AA1 5 LYS A 666 PRO A 672 -1 O LEU A 671 N ALA A 617 SHEET 5 AA1 5 GLY A 654 GLU A 658 -1 N CYS A 656 O MET A 668 SHEET 1 AA2 2 CYS A 729 LEU A 731 0 SHEET 2 AA2 2 VAL A 737 VAL A 739 -1 O CYS A 738 N MET A 730 SITE 1 AC1 12 ALA A 617 MET A 621 GLU A 637 MET A 641 SITE 2 AC1 12 LEU A 652 LEU A 671 PRO A 672 PHE A 673 SITE 3 AC1 12 MET A 674 MET A 730 ALA A 740 ASP A 741 CRYST1 92.280 94.350 71.370 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010837 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010599 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014011 0.00000